pancreatic cancer

Syndicate content

Ruth Bader Ginsburg Has Surgery for Pancreatic Cancer

Supreme Court justice Ruth Bader Ginsberg underwent surgery on Thursday for early stage pancreatic cancer. She is 75.

Get the full story...

Surgical technique enables extirpation of benign tumors of pancreas

A laparoscopic surgical technique enables extirpation of pancreatic tumours that are benign or of scant, highly localised malignant potential and that preserves the function of the organ to the maximum, at the same time significantly reducing the number of possible complications and the period of hospitalisation.

Get the full story...

Preventing pancreatic tumor growth in mice by inhibiting key protein

Researchers at Stanford University School of Medicine have identified a protein critical for the growth of pancreatic cancer. Blocking the expression of the protein slowed or prevented tumor growth in mice and made cultured cancer cells vulnerable to the conditions of low oxygen that occur in solid tumors.

Get the full story...

DNA repair patterns may predict risk of pancreatic cancer

Genetic variations in DNA repair patterns may increase risk of pancreatic cancer by as much as threefold or decrease it by as much as 77 percent, depending on the genes involved, according to a report published in the January 15, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

Get the full story...

Abnormal DNA repair genes may predict pancreatic cancer risk

Abnormalities in genes that repair mistakes in DNA replication may help identify people who are at high risk of developing pancreatic cancer, a research team from The University of Texas M. D. Anderson Cancer Center reports in the Jan. 15 issue of Clinical Cancer Research.

Get the full story...

Glitches in DNA repair genes predict prognosis in pancreatic cancer

Variations in mismatch repair genes can help predict treatment response and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in advance of the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.

Get the full story...

Hepatitis C may increase pancreatic cancer risk

A new study shows that infection with hepatitis C virus (HCV) increases a person’s risk for a highly fatal cancer of the biliary tree, the bile carrying pathway between the liver and pancreas.

Get the full story...

New discovery moves diabetes type 1 cure closer to clinical application

In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.

Get the full story...

Is it effective therapy for severe acute pancreatitis?

Severe acute pancreatitis (SAP) remains a lethal disease. It is defined as an inflammatory process of the pancreas with possible peripancreatic tissue and multi-organ involvement inducing multi-organ dysfunction syndrome (MODS) with an increased mortality rate.

Get the full story...

Leptin's long-distance call to pancreas

the cartoonist who devised complex machines for simple tasks—would have smiled at one of leptin's mechanisms for curbing insulin release. As Hinoi et al. show, the fat-derived hormone enlists the sympathetic nervous system to prevent bone-making cells from releasing a molecule that prods the pancreas to discharge insulin.

Get the full story...

Radiation before surgery improves pancreatic cancer outcomes

Pancreatic cancer is one of the deadliest and most difficult to treat cancers. Now, in a major step forward, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have shown that administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumors.

Get the full story...

Starving cancer cells of arginine cuts proliferation in half

UC Davis Cancer Center researchers have discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers.

Get the full story...